Observational Study of B-Cell Non Hodgkin Lymphomas (NHL) Associated With Hepatitis C Virus (HCV)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

138 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-11-30

Study Completion Date

2014-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

An prospective / retrospective multicenter observational study whose objectives are to understand the interactions between hepatitis c virus and Non Hodgkin lymphomas. The characteristics , evolution and treatment of diseases will be observed from the study.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Viral Load Changes in Lymphoma Patients With HCV Infection After Chemotherapy

NCT02588560

Lymphoma Hepatitis C Antibodies Drug Therapy

UNKNOWN

Retrospective Observational Study to Define HBsAg Loss With or Without Seroconversion to antiHBs in Patients With Chronic Hepatitis by B Virus Treated With Nucleoside/Nucleotide Analogs

NCT02005146

Chronic Hepatitis B Treated With Nucleoside/Nucleotide Analogues

COMPLETED

T-cell Dysfunction in Chronic HBV Infection

NCT05099458

Chronic Hepatitis B Virus

UNKNOWN NA

Association Between Hepatitis C Virus Infection and Hematologic and Thyroid Cancers

NCT00342641

Hepatitis C Virus

COMPLETED

Studies of Immune Responses in Patients With Chronic Hepatitis B

NCT00155155

Hepatitis B

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Main objectives are:

* Description of the clinical and histological characteristics, treatment and evolution of these NHL.
* Study their physiopathology by immunological, virologic and molecular studies.

The study included prospective or retrospective patients with B- Cell Non-Hodgkin lymphomas (NHL) associated with chronic hepatitis C. The patients are diagnosed or in remission of lymphoma, in relapse or failure of treatments.

The enrolment period is 6 years and the total study lasts 8 years.

* "Prospective patients" are followed every 6 months during one year, and all the years during 2 or 5 years.
* "Retropective patients" are followed all the years during 2 or 5 years. At each follow-up, a blood sample of 50ml is withdrawn allowing ancillary studies.

The enrollment is estimated at 140 patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Hepatitis C

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with evolving NHL whatever its histological type
* At diagnosis or relapse or failure previous treatments stopped over 3 months
* Patients with HCV infection with positive quantitative viral load
* 18 years or more of age
* Life expectancy greater than 6 months
* Signed and informed consent
* Benefit from social security